Cooperative group trials in pediatric oncology: The surgeon's role

被引：8
|
作者：
Shamberger, Robert C. [1 ,2 ]
机构：
[1] Childrens Hosp, Dept Surg, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
来源：
JOURNAL OF PEDIATRIC SURGERY | 2013年 / 48卷 / 01期
关键词：
Children's Cancer Study Group; Intergroup Rhabdomyosarcoma Study; Pediatric Oncology Group; National Wilms Tumor Study Group; Cooperative group trials; Neuroblastoma; Wilms tumor; Rhabdomyosarcoma; Ewing's sarcoma; Osteosarcoma; NATIONAL WILMS-TUMOR; CHILDRENS CANCER GROUP; SARCOMA/PRIMITIVE NEUROECTODERMAL TUMOR; HIGH-RISK NEUROBLASTOMA; INTERGROUP RHABDOMYOSARCOMA; EWINGS-SARCOMA; RADIATION-THERAPY; PROGNOSTIC-SIGNIFICANCE; NEURO-BLASTOMA; STANDARD CHEMOTHERAPY;
D O I：
10.1016/j.jpedsurg.2012.10.068
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
The early history of the pediatric cooperative group trials is reviewed, and the surgeons who played a critical role in their formation are discussed. The vital information provided from the tumor specimens submitted as part of the protocols is presented, as well as how this information advanced our management of infants and children treated on current protocols of the Children's Oncology Group. Finally, a survey of the surgeons currently active in the clinical trials defined the "critical lessons" learned from the sequence of protocols by the cooperative groups which have advanced our surgical treatment of patients today. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码：1 / 13
页数：13
相关论文
共 50 条
  • [11] Children's Oncology Group's 2023 blueprint for research: Neuroblastoma
    Bagatell, Rochelle G.
    DuBois, Steven G.
    Naranjo, Arlene
    Belle, Jen C.
    Goldsmith, Kelly C. R.
    Park, Julie R. S.
    Irwin, Meredith S.
    COG Neuroblastoma Comm
    PEDIATRIC BLOOD & CANCER, 2023, 70
  • [12] Children's Oncology Group's 2013 blueprint for research: Neuroblastoma
    Park, Julie R.
    Bagatell, Rochelle
    London, Wendy B.
    Maris, John M.
    Cohn, Susan L.
    Mattay, Katherine M.
    Hogarty, Michael
    PEDIATRIC BLOOD & CANCER, 2013, 60 (06) : 985 - 993
  • [13] THORACIC NEUROBLASTOMA - A PEDIATRIC ONCOLOGY GROUP-STUDY
    ADAMS, GA
    SHOCHAT, SJ
    SMITH, EI
    SHUSTER, JJ
    JOSHI, VV
    ALTSHULER, G
    HAYES, FA
    NITSCHKE, R
    MCWILLIAMS, N
    CASTLEBERRY, RP
    JOURNAL OF PEDIATRIC SURGERY, 1993, 28 (03) : 372 - 378
  • [14] Children's Oncology Group's 2023 blueprint for research: Epidemiology
    Lupo, Philip L.
    Marcotte, Erin E.
    Scheurer, Michael N.
    Poynter, Jenny G.
    Spector, Logan
    COG Epidemiol Comm
    PEDIATRIC BLOOD & CANCER, 2023, 70
  • [15] Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials
    Metts, Jonathan L.
    Aye, Jamie M.
    Crane, Jacquelyn N.
    Oberoi, Sapna
    Balis, Frank M.
    Bhatia, Smita
    Bona, Kira
    Carleton, Bruce
    Dasgupta, Roshni
    Dela Cruz, Filemon S.
    Greenzang, Katie A.
    Kaufman, Jonathan L.
    Linardic, Corinne M.
    Parsons, Susan K.
    Robertson-Tessi, Mark
    Rudzinski, Erin R.
    Soragni, Alice
    Stewart, Elizabeth
    Weigel, Brenda J.
    Wolden, Suzanne L.
    Weiss, Aaron R.
    Venkatramani, Rajkumar
    Heske, Christine M.
    CANCER, 2024, 130 (22) : 3785 - 3796
  • [16] Hormone and fertility drug use and the risk of neuroblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group
    Olshan, AF
    Smith, J
    Cook, MN
    Grufferman, S
    Pollock, BH
    Stram, DO
    Seeger, RC
    Look, AT
    Cohn, SL
    Castleberry, RP
    Bondy, ML
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1999, 150 (09) : 930 - 938
  • [17] Cooperative Group Cancer Clinical Trials: An NCIC Clinical Trials Group Perspective
    Meyer, Ralph M.
    Stanton, Heather A.
    Parulekar, Wendy R.
    Saad, Fred
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2011, 5 (06): : 379 - 381
  • [18] An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials
    Haduong, Josephine H.
    Heske, Christine M.
    Allen-Rhoades, Wendy
    Xue, Wei
    Teot, Lisa A.
    Rodeberg, David A.
    Donaldson, Sarah S.
    Weiss, Aaron
    Hawkins, Douglas S.
    Venkatramani, Rajkumar
    PEDIATRIC BLOOD & CANCER, 2022, 69 (04)
  • [19] Outcome of patients with relapsed or refractory nonrhabdomyosarcoma soft tissue sarcomas enrolled in phase 2 cooperative group clinical trials: A report from the Children's Oncology Group
    Oberoi, Sapna
    Qumseya, Amira
    Xue, Wei
    Venkatramani, Rajkumar
    Weiss, Aaron R.
    CANCER, 2024, : 2493 - 2502
  • [20] Event-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group
    Metts, Jonathan
    Xue, Wei
    Gao, Zhengya
    Oberoi, Sapna
    Weiss, Aaron R.
    Venkatramani, Rajkumar
    Harrison, Douglas J.
    PEDIATRIC BLOOD & CANCER, 2024, 71 (07)
12345